Bot back in $INNV $0.2045 after selling into cand
Post# of 4851
![Avatar](/images/ProfileImages/934136062_182_A_Dawgg 1 Two 10-baggers at the same time..jpg)
after selling into candle .26
Big move still to come with (delayed so far)
FDA approval of over the counter Fluticare.
As the #1 prescription nasal steroid with over 177 million units sold since 2007, Innovus believes that the over-the-counter version of FlutiCare™ could be worth up to $1 billion per year by addressing a much wider over-the-counter market. Would strongly challenge Flonase, current OTC #1.
The stock is priced as if there will not be an FDA approval.
![Like This Post](/images/thumb-up.png)
![Dislike This Post](/images/thumb-down.png)